Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Verratti Mark Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 4 Verratti Mark (Chief Commercial Officer) has filed a Form 4 on MYRIAD GENETICS INC
Txns: Paid exercise price by delivering 3,360 shares @ $15.01, valued at $50.4k
Paid exercise price by delivering 5,006 shares @ $15.01, valued at $75.1k
09/27/2023 4 Verratti Mark (Chief Commercial Officer) has filed a Form 4 on MYRIAD GENETICS INC
Txns: Paid exercise price by delivering 3,523 shares @ $15.99, valued at $56.3k
04/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/27/2023 4 Verratti Mark (Chief Commercial Officer) has filed a Form 4 on MYRIAD GENETICS INC
Txns: Paid exercise price by delivering 1,083 shares @ $23.72, valued at $25.7k
Paid exercise price by delivering 1,586 shares @ $23.72, valued at $37.6k
03/23/2023 4 Verratti Mark (Chief Commercial Officer) has filed a Form 4 on MYRIAD GENETICS INC
Txns: Paid exercise price by delivering 1,351 shares @ $22.91, valued at $31k
03/16/2023 4 Verratti Mark (Chief Commercial Officer) has filed a Form 4 on MYRIAD GENETICS INC
Txns: Granted 39,405 shares @ $0
10/11/2022 4 Verratti Mark (Chief Commercial Officer) has filed a Form 4 on MYRIAD GENETICS INC
Txns: Paid exercise price by delivering 3,360 shares @ $19.62, valued at $65.9k
Paid exercise price by delivering 5,006 shares @ $19.62, valued at $98.2k
09/27/2022 4 Verratti Mark (Chief Commercial Officer) has filed a Form 4 on MYRIAD GENETICS INC
Txns: Paid exercise price by delivering 2,793 shares @ $18.69, valued at $52.2k
Paid exercise price by delivering 2,293 shares @ $18.41, valued at $42.2k
09/22/2022 4 Verratti Mark (Chief Commercial Officer) has filed a Form 4 on MYRIAD GENETICS INC
Txns: Paid exercise price by delivering 702 shares @ $20.2, valued at $14.2k
08/26/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/14/2022 4 Verratti Mark (Chief Commercial Officer) has filed a Form 4 on MYRIAD GENETICS INC
Txns: Granted 10,000 shares @ $0
03/25/2022 4 Verratti Mark (President, Mental Health) has filed a Form 4 on MYRIAD GENETICS INC
Txns: Paid exercise price by delivering 1,082 shares @ $25.32, valued at $27.4k
Paid exercise price by delivering 1,584 shares @ $25.32, valued at $40.1k
03/23/2022 4 Verratti Mark (President, Mental Health) has filed a Form 4 on MYRIAD GENETICS INC
Txns: Granted 19,238 shares @ $0
02/18/2022 4 Verratti Mark (President, Mental Health) has filed a Form 4 on MYRIAD GENETICS INC
Txns: Granted 22,616 shares @ $0
10/12/2021 4 Verratti Mark (President, Myriad Neuroscience) has filed a Form 4 on MYRIAD GENETICS INC
Txns: Paid exercise price by delivering 3,349 shares @ $30.88, valued at $103.4k
Paid exercise price by delivering 4,991 shares @ $30.88, valued at $154.1k
09/27/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/26/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/26/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/13/2020 4 Verratti Mark (President Assurex Health Inc.) has filed a Form 4 on MYRIAD GENETICS INC
Txns: Granted 31,258 shares @ $0
10/01/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/28/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/17/2020 4 Verratti Mark (President Assurex Health Inc.) has filed a Form 4 on MYRIAD GENETICS INC
Txns: Granted 7,467 shares @ $0
10/01/2019 4 Verratti Mark (President Assurex Health Inc.) has filed a Form 4 on MYRIAD GENETICS INC
Txns: Disposed/sold 725 shares @ $28.63, valued at $20.8k
09/26/2019 4 Verratti Mark (President Assurex Health Inc.) has filed a Form 4 on MYRIAD GENETICS INC
Txns: Disposed/sold 2,897 shares @ $29.93, valued at $86.7k
10/02/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/26/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/21/2018 4 Verratti Mark (President Assurex Health Inc.) has filed a Form 4 on MYRIAD GENETICS INC
Txns: Granted 40,000 shares @ $0
10/03/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/15/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/18/2014 4 Form 4 - Statement of changes in beneficial ownership of securities
12/05/2013 4 Verratti Mark (VP Global Sales) has filed a Form 4 on CYBERONICS INC
Txns: Sold 18,750 shares @ $71.1188, valued at $1.3M
Exercised 18,750 options to buy @ $37.9, valued at $710.6k
12/02/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
06/21/2013 4 Verratti Mark (VP Global Sales) has filed a Form 4 on CYBERONICS INC
Txns: Paid exercise price by delivering 777 shares @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy